Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug ClaimsTip Ranks·18 hours agoREGN+0.90%
05:13 ETKeymed Biosciences Announces 2026 H1 Results and Business Updatesprnewswire·20 hours ago02162+3.28%GILD+1.87%
04:39 ETRegeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REGNprnewswire·21 hours agoREGN+0.90%
The Bull Case For Vertex (VRTX) Could Change Following Upgraded 2026 Guidance And Pipeline Momentum - Learn WhySimplywall·22 hours agoVRTX+1.44%
argenx (ENXTBR:ARGX) Hits A Phase 3 Win, Is The Upside Fully Priced?Simplywall·1 day ago, 02:44 PMARGX+0.16%
Why Iovance Biotherapeutics Stock Hit 52-Week Highbenzinga_article·1 day ago, 12:14 PMIOVA-7.79%MRNA+8.86%
Regeneron Secures FDA Approval For Ultra-Rare Bone Disorder Drugbenzinga_article·1 day ago, 08:25 AMREGN+0.90%
Pharma Bro Admits 'Playing Around' With MRNA Short At $80 Before it Exploded 177% Following Cancer Vax Trials— ‘I Bet You a Bunch of People Got Fired’benzinga_article·1 day ago, 07:53 AMMRNA+8.86%MRNY+7.56%
FY2029 Earnings Estimate for argenex Issued By HC WainwrightMarket Beat·1 day ago, 06:27 AMARGX+0.16%
Diversify Advisory Services LLC Buys New Holdings in Regeneron Pharmaceuticals, Inc. $REGNMarket Beat·21 hours agoREGN+0.90%
Keymed Biosciences Announces 2026 H1 Results and Business Updates | LKFT Stock NewsStockTitan·1 day ago, 01:09 AM02162+3.28%AZN+0.91%
22:26 ETREGN Stockholders Interested in Leading the Class Action Against Regeneron Pharmaceuticals, Inc. Should Contact Robbins LLP for Information About Recovering Their Lossesprnewswire·2 days ago, 09:26 PMREGN+0.90%
Moderna's cancer-vaccine breakthrough drives broad biopharma stock rallyMarketWatch·2 days ago, 07:28 PMLLY+0.88%AMGN+1.88%
Virtus Advisers LLC Takes $1.01 Million Position in Natera, Inc. $NTRAMarket Beat·19 hours agoNTRA+2.21%
